\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\:bp\\ 115\\/75\\,\\ hr\\ 106\\,\\ rr\\ 18\\,\\ o2\\ 90\\%\\ on\\ 2\\-4\\ lnc\ \(0\)\
\-\ gen\\:\\ alert\\ and\\ oriented\\,\\ in\\ no\\ acute\\ distress\\.\\ \ \(0\)\
\-\ heent\\:\\ extensive\\ jvd\\ while\\ upright\\.\\ \ \(0\)\
\-\ heart\\:\\ normal\\ s1\\,\\ s2\\.\\ no\\ murmurs\\,\\ rubs\\,\\ gallops\\.\ \(0\)\
\-\ chest\\:\\ coarse\\ breath\\ sounds\\ bilaterally\\.\\ both\\ breasts\\ were\\ enlarged\\.\ \(0\)\
\-\ abd\\:\\ unremarkable\ \(0\)\
\-\ neuro\\:\\ no\\ focal\\ deficits\ \(0\)\
\-\ this\\ woman\\ has\\ a\\ past\\ medical\\ history\\ of\\ non\\-small\\ cell\\ lung\\ cancer\\,\\ status\\ post\\ external\\ beam\\ radiotherapy\\ and\\ chemotherapy\\.\\ \\ she\\ was\\ treated\\ palliatively\\ with\\ venous\\ stent\\ placement\\ to\\ relieve\\ the\\ venous\\ obstruction\\.\ \(0\)\
\-\ \\â\\€\\¢cxr\\:\\ bilateral\\ breast\\ enlargement\\,\\ blunting\\ of\\ the\\ costophrenic\\ sulci\\,\\ bilateral\\ pleural\\ effusions\\,\\ consolidation\\ of\\ the\\ right\\ upper\\ lobe\ \(0\)\
\-\ \\â\\€\\¢ct\\:\\ bilateral\\ breast\\ enlargement\\,\\ right\\ sided\\ pleural\\ effusion\\,\\ elevation\\ of\\ the\\ right\\ hemidiaphragm\\,\\ right\\ upper\\ lobe\\ mass\\ causing\\ occlusion\\ of\\ the\\ right\\ brachiocephalic\\ vein\\,\\ extensive\\ venous\\ collateral\\ formation\ \(0\)\
\-\ superior\\ vena\\ cava\\ syndrome\\ secondary\\ to\\ lung\\ cancer\ \(0\)\
\-\ svc\\ syndrome\ \(0\)\
\-\ malignancy\\ related\ \(1\)\
\-\ secondary\\ to\\ thrombosis\ \(3\)\
\-\ fibrosing\\ mediastinitis\ \(4\)\
\-\ post\\-radiation\\ fibrosis\ \(1\)\
\-\ sarcoidosis\ \(108\)\
\-\ inflammatory\\ breast\\ cancer\ \(3\)\
\-\ pulmonary\\ htn\ \(0\)\
\-\ 59\\ year\\-old\\ woman\\ presents\\ with\\ facial\\ swelling\\ and\\ discomfort\\ in\\ her\\ breasts\\.\\ \\ these\\ symptoms\\ are\\ worse\\ in\\ the\\ morning\\,\\ and\\ are\\ exacerbated\\ when\\ lying\\ flat\\.\\ the\\ patient\\ also\\ endorses\\ worsening\\ orthopnea\\.\ \(0\)\
\-\ this\\ patient\\'s\\ lung\\ cancer\\ was\\ refractory\\ to\\ radiation\\ and\\ chemotherapy\\.\\ therefore\\,\\ when\\ she\\ started\\ to\\ experience\\ swelling\\ in\\ her\\ face\\ and\\ chest\\,\\ svc\\ syndrome\\ would\\ have\\ been\\ at\\ the\\ top\\ of\\ the\\ differential\\ since\\ it\\ is\\ a\\ fairly\\ common\\ complication\\ of\\ this\\ type\\ of\\ malignancy\\.\\ her\\ lung\\ cancer\\ was\\ most\\ likely\\ related\\ to\\ her\\ smoking\\ history\\.\\ the\\ patient\\ could\\ very\\ well\\ have\\ a\\ component\\ of\\ post\\ radiation\\ fibrosis\\ contributing\\ to\\ the\\ occlusion\\ of\\ the\\ svc\\,\\ but\\ the\\ malignancy\\ was\\ the\\ main\\ contributor\\.\\ \\ surgery\\ was\\ not\\ an\\ option\\ for\\ this\\ patient\\,\\ due\\ to\\ the\\ overwhelming\\ tumor\\ burden\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ svc\\:\\ 0\\.05061520535807349\ \(0\)\
\-\ cancer\\:\\ 0\\.04321792714407331\ \(0\)\
\-\ breasts\\:\\ 0\\.03254866399600207\ \(0\)\
\-\ her\\:\\ 0\\.031623528104429977\ \(0\)\
\-\ \\:\\:\\ 0\\.03129991798127996\ \(0\)\
\-\ lung\\:\\ 0\\.030463496864476875\ \(0\)\
\-\ breast\\:\\ 0\\.029100534866128177\ \(0\)\
\-\ venous\\:\\ 0\\.028631867247296577\ \(0\)\
\-\ 115\\/75\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ lnc\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ palliatively\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ \\-fibrosing\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ \\-post\\-radiation\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ occlusion\\:\\ 0\\.026225486353021278\ \(0\)\
\-\ \\â\\€\\¢cxr\\:\\ 0\\.02499191151817401\ \(0\)\
\-\ \\-secondary\\:\\ 0\\.02499191151817401\ \(0\)\
\-\ \\-sarcoidosis\\:\\ 0\\.02499191151817401\ \(0\)\
\-\ orthopnea\\:\\ 0\\.02499191151817401\ \(0\)\
\-\ fibrosis\\:\\ 0\\.023414665414586106\ \(0\)\
\-\ syndrome\\:\\ 0\\.022559137631396692\ \(0\)\
\-\ related\\:\\ 0\\.021706162420135157\ \(0\)\
\-\ \\â\\€\\¢ct\\:\\ 0\\.021611566014579826\ \(0\)\
\-\ overwhelming\\:\\ 0\\.021611566014579826\ \(0\)\
\-\ \\-malignancy\\:\\ 0\\.021137256230495952\ \(0\)\
\-\ extensive\\:\\ 0\\.021029881368915357\ \(0\)\
\-\ enlargement\\:\\ 0\\.020865036347600587\ \(0\)\
\-\ 106\\:\\ 0\\.020726390407035885\ \(0\)\
\-\ pleural\\:\\ 0\\.020420616607220284\ \(0\)\
\-\ malignancy\\:\\ 0\\.020320551863393942\ \(0\)\
\-\ contributor\\:\\ 0\\.020039794864530624\ \(0\)\
\-\ 2\\-4\\:\\ 0\\.019478805459010762\ \(0\)\
\-\ brachiocephalic\\:\\ 0\\.019478805459010762\ \(0\)\
\-\ endorses\\:\\ 0\\.019478805459010762\ \(0\)\
\-\ bilateral\\:\\ 0\\.019142932885979486\ \(0\)\
\-\ mediastinitis\\:\\ 0\\.019004495674926892\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.018848897139328403\ \(0\)\
\-\ burden\\:\\ 0\\.0187922099165055\ \(0\)\
\-\ jvd\\:\\ 0\\.018064859830154024\ \(0\)\
\-\ non\\-small\\:\\ 0\\.01790703430896156\ \(0\)\
\-\ beam\\:\\ 0\\.01775691072690177\ \(0\)\
\-\ blunting\\:\\ 0\\.017613772217255946\ \(0\)\
\-\ contributing\\:\\ 0\\.017613772217255946\ \(0\)\
\-\ swelling\\:\\ 0\\.01751883608603774\ \(0\)\
\-\ radiation\\:\\ 0\\.017256930766537455\ \(0\)\
\-\ costophrenic\\:\\ 0\\.0172204387664563\ \(0\)\
\-\ exacerbated\\:\\ 0\\.01709975964906159\ \(0\)\
\-\ \\,\\:\\ 0\\.016659080954909995\ \(0\)\
\-\ post\\:\\ 0\\.016558984818906424\ \(0\)\
\-\ upright\\:\\ 0\\.01655855759840416\ \(0\)\
\-\ relieve\\:\\ 0\\.016274331998001035\ \(0\)\
\-\ refractory\\:\\ 0\\.016274331998001035\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.016014155419453148\ \(0\)\
\-\ gallops\\:\\ 0\\.015698296483883663\ \(0\)\
\-\ coarse\\:\\ 0\\.015551748640839802\ \(0\)\
\-\ flat\\:\\ 0\\.015411864412911319\ \(0\)\
\-\ fairly\\:\\ 0\\.015411864412911319\ \(0\)\
\-\ hemidiaphragm\\:\\ 0\\.015278064068481353\ \(0\)\
\-\ was\\:\\ 0\\.01520426957251826\ \(0\)\
\-\ o2\\:\\ 0\\.015087678210887237\ \(0\)\
\-\ rubs\\:\\ 0\\.015087678210887237\ \(0\)\
\-\ when\\:\\ 0\\.015060499923790804\ \(0\)\
\-\ sulci\\:\\ 0\\.015026747049975914\ \(0\)\
\-\ stent\\:\\ 0\\.014794416119181622\ \(0\)\
\-\ lying\\:\\ 0\\.014794416119181622\ \(0\)\
\-\ she\\:\\ 0\\.014761760870487214\ \(0\)\
\-\ option\\:\\ 0\\.014684514326559841\ \(0\)\
\-\ gen\\:\\ 0\\.014475829414748268\ \(0\)\
\-\ s2\\:\\ 0\\.014475829414748268\ \(0\)\
\-\ htn\\:\\ 0\\.014475829414748268\ \(0\)\
\-\ experience\\:\\ 0\\.014425797042835097\ \(0\)\
\-\ morning\\:\\ 0\\.014376565223307587\ \(0\)\
\-\ lobe\\:\\ 0\\.014149694448760209\ \(0\)\
\-\ murmurs\\:\\ 0\\.014141571442431973\ \(0\)\
\-\ 59\\:\\ 0\\.014141571442431973\ \(0\)\
\-\ top\\:\\ 0\\.014096652059597658\ \(0\)\
\-\ abd\\:\\ 0\\.0139232584086711\ \(0\)\
\-\ vena\\:\\ 0\\.0139232584086711\ \(0\)\
\-\ right\\:\\ 0\\.01387125706323718\ \(0\)\
\-\ cava\\:\\ 0\\.013840093262862117\ \(0\)\
\-\ collateral\\:\\ 0\\.01375911692957789\ \(0\)\
\-\ s1\\:\\ 0\\.0135655359283146\ \(0\)\
\-\ neuro\\:\\ 0\\.0135655359283146\ \(0\)\
\-\ rr\\:\\ 0\\.013418988085270738\ \(0\)\
\-\ effusions\\:\\ 0\\.013418988085270738\ \(0\)\
\-\ smoking\\:\\ 0\\.013279103857342257\ \(0\)\
\-\ consolidation\\:\\ 0\\.013178212094809976\ \(0\)\
\-\ discomfort\\:\\ 0\\.013178212094809976\ \(0\)\
\-\ alert\\:\\ 0\\.013112743176510639\ \(0\)\
\-\ elevation\\:\\ 0\\.012985841765636642\ \(0\)\
\-\ oriented\\:\\ 0\\.012893986494406852\ \(0\)\
\-\ face\\:\\ 0\\.012893986494406852\ \(0\)\
\-\ complication\\:\\ 0\\.012893986494406852\ \(0\)\
\-\ hr\\:\\ 0\\.012804794073258385\ \(0\)\
\-\ heent\\:\\ 0\\.012718114451822395\ \(0\)\
\-\ upper\\:\\ 0\\.012689726186884421\ \(0\)\
\-\ chest\\:\\ 0\\.012582947692661653\ \(0\)\
\-\ therefore\\:\\ 0\\.01241967671032298\ \(0\)\
\-\ 90\\:\\ 0\\.012393928249798316\ \(0\)\
\-\ main\\:\\ 0\\.012243804667738525\ \(0\)\
\-\ woman\\:\\ 0\\.012147095061470192\ \(0\)\
\-\ deficits\\:\\ 0\\.012031518909317135\ \(0\)\
\-\ component\\:\\ 0\\.012008810886862911\ \(0\)\
\-\ this\\:\\ 0\\.011829381086943177\ \(0\)\
\-\ started\\:\\ 0\\.011727914209295505\ \(0\)\
\-\ worse\\:\\ 0\\.01164640154638173\ \(0\)\
\-\ facial\\:\\ 0\\.011432775372745537\ \(0\)\
\-\ bp\\:\\ 0\\.011414070615587439\ \(0\)\
\-\ 18\\:\\ 0\\.011414070615587439\ \(0\)\
\-\ have\\:\\ 0\\.011387311251477487\ \(0\)\
\-\ causing\\:\\ 0\\.011358629060194582\ \(0\)\
\-\ thrombosis\\:\\ 0\\.011286227529701678\ \(0\)\
\-\ external\\:\\ 0\\.011180722688228964\ \(0\)\
\-\ distress\\:\\ 0\\.011078715896484653\ \(0\)\
\-\ formation\\:\\ 0\\.010853081210067578\ \(0\)\
\-\ placement\\:\\ 0\\.010672033517689321\ \(0\)\
\-\ patient\\:\\ 0\\.010542669918970928\ \(0\)\
\-\ to\\:\\ 0\\.010512445746288892\ \(0\)\
\-\ sounds\\:\\ 0\\.0104872204692504\ \(0\)\
\-\ vs\\:\\ 0\\.010352246062771686\ \(0\)\
\-\ worsening\\:\\ 0\\.010352246062771686\ \(0\)\
\-\ effusion\\:\\ 0\\.009991304369862774\ \(0\)\
\-\ breath\\:\\ 0\\.009831130948459534\ \(0\)\
\-\ sided\\:\\ 0\\.009721620348143525\ \(0\)\
\-\ could\\:\\ 0\\.009700178288709392\ \(0\)\
\-\ year\\-old\\:\\ 0\\.009657737297532974\ \(0\)\
\-\ since\\:\\ 0\\.009657737297532974\ \(0\)\
\-\ very\\:\\ 0\\.009543955749098859\ \(0\)\
\-\ vein\\:\\ 0\\.009513640990812668\ \(0\)\
\-\ status\\:\\ 0\\.00938562252671278\ \(0\)\
\-\ would\\:\\ 0\\.00935682116437566\ \(0\)\
\-\ obstruction\\:\\ 0\\.009272000149505955\ \(0\)\
\-\ heart\\:\\ 0\\.009135629688950073\ \(0\)\
\-\ inflammatory\\:\\ 0\\.009117895212898535\ \(0\)\
\-\ enlarged\\:\\ 0\\.008971141755027712\ \(0\)\
\-\ type\\:\\ 0\\.00886345916414434\ \(0\)\
\-\ unremarkable\\:\\ 0\\.008704819749790956\ \(0\)\
\-\ bilaterally\\:\\ 0\\.008636016118535088\ \(0\)\
\-\ superior\\:\\ 0\\.008396134452474434\ \(0\)\
\-\ past\\:\\ 0\\.008354459913681335\ \(0\)\
\-\ differential\\:\\ 0\\.008347568705701322\ \(0\)\
\-\ while\\:\\ 0\\.008272766891853273\ \(0\)\
\-\ medical\\:\\ 0\\.00809018400020309\ \(0\)\
\-\ no\\:\\ 0\\.007942561391112019\ \(0\)\
\-\ treated\\:\\ 0\\.007870310264873413\ \(0\)\
\-\ pulmonary\\:\\ 0\\.00768169326221558\ \(0\)\
\-\ focal\\:\\ 0\\.0075092110896566215\ \(0\)\
\-\ likely\\:\\ 0\\.007416276818263559\ \(0\)\
\-\ secondary\\:\\ 0\\.0073508614354117156\ \(0\)\
\-\ history\\:\\ 0\\.007262858693582052\ \(0\)\
\-\ are\\:\\ 0\\.007168454600182165\ \(0\)\
\-\ been\\:\\ 0\\.0071532150445045885\ \(0\)\
\-\ cell\\:\\ 0\\.00710227911255842\ \(0\)\
\-\ due\\:\\ 0\\.007016237393701045\ \(0\)\
\-\ common\\:\\ 0\\.006880822190635068\ \(0\)\
\-\ these\\:\\ 0\\.00684259905217797\ \(0\)\
\-\ both\\:\\ 0\\.00671446150980345\ \(0\)\
\-\ symptoms\\:\\ 0\\.006552792236609659\ \(0\)\
\-\ acute\\:\\ 0\\.006491936397250754\ \(0\)\
\-\ surgery\\:\\ 0\\.006384612505723923\ \(0\)\
\-\ the\\:\\ 0\\.006380736217090422\ \(0\)\
\-\ \\%\\:\\ 0\\.006133295487218485\ \(0\)\
\-\ tumor\\:\\ 0\\.0061299455434178805\ \(0\)\
\-\ most\\:\\ 0\\.006070261974547926\ \(0\)\
\-\ were\\:\\ 0\\.005970111805199758\ \(0\)\
\-\ well\\:\\ 0\\.005947941393749695\ \(0\)\
\-\ it\\:\\ 0\\.005910302721640052\ \(0\)\
\-\ \\'s\\:\\ 0\\.0057970665180524465\ \(0\)\
\-\ but\\:\\ 0\\.005607702464718577\ \(0\)\
\-\ presents\\:\\ 0\\.005371213216947464\ \(0\)\
\-\ in\\:\\ 0\\.005186427447880061\ \(0\)\
\-\ also\\:\\ 0\\.005183444903600466\ \(0\)\
\-\ has\\:\\ 0\\.004937538370751625\ \(0\)\
\-\ normal\\:\\ 0\\.004121884475689542\ \(0\)\
\-\ not\\:\\ 0\\.0037994420668982626\ \(0\)\
\-\ a\\:\\ 0\\.0036609212475563198\ \(0\)\
\-\ mass\\:\\ 0\\.0036568030983001984\ \(0\)\
\-\ an\\:\\ 0\\.003635891890106861\ \(0\)\
\-\ of\\:\\ 0\\.003584732332245798\ \(0\)\
\-\ at\\:\\ 0\\.0035623481625588708\ \(0\)\
\-\ and\\:\\ 0\\.0033232431827486487\ \(0\)\
\-\ for\\:\\ 0\\.002243409688131431\ \(0\)\
\-\ on\\:\\ 0\\.0022273569611243943\ \(0\)\
\-\ \\.\\:\\ 0\\.0017476694694078165\ \(0\)\
\-\ is\\:\\ 0\\.001730125471953002\ \(0\)\
\-\ with\\:\\ 0\\.000720025699014706\ \(0\)\
